MURPHY ANDREW J
Reporting owner on Forms 3, 4 and 5, CIK 1796226.
MURPHY ANDREW J reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-15.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | officer (Co-Chief Scientific Officer) | 1 | 2026-10-15 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -6 | $753.76 | 51,974 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -35 | $755.91 | 51,939 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -16 | $757.68 | 51,923 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -24 | $758.16 | 51,899 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -14 | $759.96 | 51,885 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -74 | $760.65 | 51,811 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -27 | $761.36 | 51,784 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -55 | $762.57 | 51,729 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -25 | $763.76 | 51,704 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -219 | $764.4 | 51,485 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -271 | $765.39 | 51,214 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -279 | $766.47 | 50,935 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -192 | $767.39 | 50,743 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -105 | $768.33 | 50,638 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -127 | $769.3 | 50,511 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -12 | $770.2 | 50,499 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -283 | $771.56 | 50,216 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -211 | $772.56 | 50,005 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -224 | $773.4 | 49,781 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -121 | $774.48 | 49,660 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -376 | $775.46 | 49,284 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -66 | $776.31 | 49,218 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -38 | $777.76 | 49,180 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -454 | $778.64 | 48,726 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -380 | $779.59 | 48,346 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -463 | $780.63 | 47,883 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-14 | S sold | -50 | $781.47 | 47,833 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-13 | M exercised | +17,000 | $381.92 | 64,833 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-10-13 | F withheld for tax | -12,853 | $754.58 | 51,980 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 4,414 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-10-13 | M exercised | -17,000 | $0 | 17,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001796226-26-000002 | REGENERON PHARMACEUTICALS, INC. | 2026-10-15 |